| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 15, 2019 | 13.62 | 14.40 | 12.70 | 13.38 | 5,923,374 |
| Feb 14, 2019 | 17.20 | 17.20 | 13.98 | 14.00 | 6,563,274 |
| Feb 13, 2019 | 19.72 | 20.02 | 16.64 | 17.20 | 4,143,351 |
| Feb 12, 2019 | 21.70 | 22.00 | 19.50 | 20.00 | 2,886,039 |
| Feb 11, 2019 | 19.00 | 22.82 | 19.00 | 21.75 | 5,510,850 |
| Name | Futura Medical | Epic | FUM |
|---|---|---|---|
| ISIN | GB0033278473 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 7,500 | Prev Close | 13.38 |
| Shares in Issue (m) | 204.66 | Market Cap (£m) | 28.65 |
| PE Ratio | -4.33 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -3.23 | EPS Growth (%) | 11.51 |
| PEG | -0.38 | DPS Growth (%) | n/a |
| ROCE | -53.13 | Net Gearing | -81.87 |
| Quick Ratio | 18.98 | Current Ratio | 19.12 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 23 Mar | N+1 Singer | Corporate | 13.38 | - | - | Reiterates |
| 22 Mar | N+1 Singer | Corporate | 13.38 | - | - | Reiterates |
| 06 Mar | N+1 Singer | Corporate | 13.38 | - | - | Reiterates |
| 10 Jan | N+1 Singer | Corporate | 13.38 | - | - | Reiterates |
| 05 Jan | N+1 Singer | Corporate | 13.38 | - | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 11 Jan 2019 | Jonathan Freeman | In Lieu of Fees/Salary | 19,578 @ 25.10p | £4,914.08 |
| 11 Jan 2019 | John Clarke | In Lieu of Fees/Salary | 57,250 @ 25.10p | £14,369.75 |
| 13 Nov 2018 | James Barder | Buy | 357,142 @ 7.00p | £24,999.94 |
| 13 Nov 2018 | Jonathan Freeman | Buy | 7,478 @ 7.00p | £523.46 |
| 13 Nov 2018 | Ken James | Buy | 285,714 @ 7.00p | £19,999.98 |
